Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib

References

• ChenJZaidiSRaoSAnalysis of genomes and transcriptomes of hepatocellular carcinomas identifies mutations and gene expression changes in the transforming growth factor-β pathwayGastroenterology2018154119521028918914
   PubMed Web of Science ®Google Scholar
• GuoHWuTLuQSurgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stagesCancer Manag Res20181036136929503583
   PubMed Web of Science ®Google Scholar
• ShermanMRegorafenib for treatment of hepatocellular carcinomaHepatology20186731162116529059458
   PubMed Web of Science ®Google Scholar
• ReissKAYuSMamtaniRStarting dose of sorafenib for the treatment of hepatocellular carcinoma: a retrospective, multi-institutional studyJ Clin Oncol201735313575358128872925
   PubMed Web of Science ®Google Scholar
• KimDWTalatiCKimRHepatocellular carcinoma (HCC): beyond sorafenib-chemotherapyJ Gastrointest Oncol20178225626528480065
   PubMed Web of Science ®Google Scholar
• ZhuYJZhengBWangHYChenLNew knowledge of the mechanisms of sorafenib resistance in liver cancerActa Pharmacol Sin201738561462228344323
   PubMed Web of Science ®Google Scholar
• LiJWuPWZhouYRage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagyCell Death Dis20189222529445087
   PubMedGoogle Scholar
• RaufiATironaMTProspect of the use of checkpoint inhibitors in hepatocellular cancer treatmentsCancer Manag Res20179192728223846
   PubMed Web of Science ®Google Scholar
• ChoiHYParkNNaJBKoESParkJYYooJCDirect binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cellsOncol Rep20163521147115226719032
   PubMed Web of Science ®Google Scholar
• JungNDaiBGentlesAJMajetiRFeinbergAPAn LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesisNat Commun20156848926444494
   PubMed Web of Science ®Google Scholar
• WeiSZhongLWangXZhangWLow expression of GATA3 promotes cell proliferation and metastasis in gastric cancerCancer Manag Res2017976978029263701
   PubMed Web of Science ®Google Scholar
• YingHXuZChenMZhouSLiangXCaiXOverexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteinsOnco Targets Ther20181168970229440916
   PubMed Web of Science ®Google Scholar
• ZhaoJBaiZFengFCross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cellInt J Biochem Cell Biol201672738826783937
   PubMed Web of Science ®Google Scholar
• HouJHongZFengFA novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinomaBMC Cancer201717172929117859
   PubMed Web of Science ®Google Scholar
• FengFLuYYZhangFLong interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinomaWorld J Gastroenterol20131971068107823466962
   PubMed Web of Science ®Google Scholar
• ChenYFengFGaoXmiRNA153 reduces effects of chemotherapeutic agents or small molecular kinase inhibitor in HCC cellsCurr Cancer Drug Targets201515317618725714700
   PubMed Web of Science ®Google Scholar
• LiLKangLZhaoWmiR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effectCancer Lett2017400899828461244
   PubMed Web of Science ®Google Scholar
• FengYXuXZhangYHPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasionSci Rep20155942925800793
   PubMed Web of Science ®Google Scholar
• MaDJiaHQinMmiR-122 induces radiosensitization in non-small cell lung cancer cell lineInt J Mol Sci2015169221372215026389880
   PubMed Web of Science ®Google Scholar
• CostaGAde SouzaSBda Silva TeixeiraLRTumor cell cholesterol depletion and V-ATPase inhibition as an inhibitory mechanism to prevent cell migration and invasiveness in melanomaBiochim Biophys Acta20181862368469129253593
   PubMed Web of Science ®Google Scholar
• JiaHYangQWangTRhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agentsBiochim Biophys Acta2016186071417143027091611
   PubMed Web of Science ®Google Scholar
• AnLLiDDChuHXTerfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversalPharmacol Res201712410511528754458
   PubMed Web of Science ®Google Scholar
• FengFJiangQCaoSPregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinomaBiochim Biophys Acta2018186241017103029369785
   PubMed Web of Science ®Google Scholar
• XuXFanZLiangCA signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityNat Commun201781405928094252
   PubMed Web of Science ®Google Scholar
• MoWZhangJLiXIdentification of novel AR-targeted microR-NAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancerPLoS One201382e5659223451058
   PubMed Web of Science ®Google Scholar
• LinHCZhangFLGengQQuantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLCJ Proteome Res20131273423343323713811
   PubMed Web of Science ®Google Scholar
• FuLFuHQiaoJHigh expression of CPNE3 predicts adverse prognosis in acute myeloid leukemiaCancer Sci201710891850185728670859
   PubMed Web of Science ®Google Scholar
• VegaJFRamosJCruzVLMolecular and hydrodynamic properties of human epidermal growth factor receptor HER2 extracellular domain and its homodimer: experiments and multi-scale simulationsBiochim Biophys Acta2017186192406241628642126
   PubMed Web of Science ®Google Scholar
• HoeslCRöhrlJMSchneiderMRDahlhoffMThe receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferationBiochim Biophys Acta20181862495896629410073
   PubMed Web of Science ®Google Scholar
• OhSKimHNamKShinIEgr-1 is required for neu/HER2-induced mammary tumorsCell Signal20184510210929408223
   PubMed Web of Science ®Google Scholar
• EzzoukhryZLouandreCTrécherelEEGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenibInt J Cancer2012131122961296922514082
   PubMed Web of Science ®Google Scholar
• Blivet-Van EggelpoëlMJChettouhHFartouxLEpidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cellsJ Hepatol201257110811522414764
   PubMed Web of Science ®Google Scholar
• BodzinASWeiZHurttRGuTDoriaCGefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocationJ Cell Physiol201222772947295221959795
   PubMed Web of Science ®Google Scholar
• XianZHZhangSHCongWMWuWQWuMCOverexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinomaJ Clin Pathol200558550050315858121
   PubMed Web of Science ®Google Scholar
• HsuCHuangCLHsuHCLeePHWangSJChengALHER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivityCancer200294241542011900227
   PubMed Web of Science ®Google Scholar
• ZhengLXuMXuJELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinomaCell Death Dis20189338729523781
   PubMedGoogle Scholar
• HouJGeCCuiMPigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomasCell Death Dis201788e296928771223
   PubMedGoogle Scholar
• HammoudaMBRiahi-ChebbiISouidSMacrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatinBiochim Biophys Acta20181862360061429196192
   PubMed Web of Science ®Google Scholar
• BeckBBlanpainCUnravelling cancer stem cell potentialNat Rev Cancer2013131072773824060864
   PubMed Web of Science ®Google Scholar
• ZeunerADe MariaRNot so lonely at the top for cancer stem cellsCell Stem Cell20119428929021982226
   PubMed Web of Science ®Google Scholar
• VisvaderJELindemanGJCancer stem cells in solid tumours: accumulating evidence and unresolved questionsNat Rev Cancer200881075576818784658
   PubMed Web of Science ®Google Scholar
• KumarRYuFZhenYHPD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+ PD-L1+ cancer cellsOnco Targets Ther2017103453346528761354
   PubMed Web of Science ®Google Scholar
• MitraAYanJXiaXIL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient β2-spectrin+/-miceHepatology20176541222123627863449
   PubMed Web of Science ®Google Scholar
• YamashitaTHondaMNakamotoYDiscrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinomaHepatology20135741484149723174907
   PubMed Web of Science ®Google Scholar
• WangYXuMKeZJLuoJCellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancerPharmacol Res201711529930827939360
   PubMed Web of Science ®Google Scholar
• MarchettiPTrinhAKhamariRKluzaJMelanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitorsBiochim Biophys Acta201818624999100529413908
   PubMed Web of Science ®Google Scholar